Iridian Asset Management’s iBio IBIO Stock Holding History

Iridian Asset Management’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-58,205	Closed	-$234K	–	44
2025 Q1	$234K	Buy	+58,205	New	+$226K	0.07%	44

Other funds holding IBIO

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Iridian Asset Management's IBIO Position: Q2 2025 in Review

Iridian Asset Management sold out of iBio (IBIO) in Q2 2025, closing a stake of 58,205 shares — an estimated $234K sold.

Iridian Asset Management first reported a position in IBIO in Q1 2025 and held it in 1 quarter. The position peaked at $234K in Q1 2025. 30 funds tracked by Wall St. Rank hold IBIO as of Q2 2025.

Iridian Asset Management reported no remaining iBio position as of Q2 2025 after selling out during the quarter.
Iridian Asset Management sold 58,205 iBio shares in Q2 2025, an estimated $234K.
Iridian Asset Management first reported a position in iBio in Q1 2025 and held it in 1 quarter.
Iridian Asset Management's iBio position peaked at $234K in Q1 2025.
30 funds tracked by Wall St. Rank held iBio as of Q2 2025.

Based on Iridian Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.